KIMBERLY BORRIS: Open Payments
NPI 1174528244 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 18 payments from 9 companies in 2025. Trend: 2023 $877 · 2024 $459 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $82 |
| Novo Nordisk Inc | 4 | $79 |
| Amgen Inc. | 2 | $46 |
| Abbott Laboratories | 2 | $33 |
| Exact Sciences Corporation | 2 | $31 |
| ABBVIE INC. | 1 | $19 |
| HEARTFLOW, INC. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REPATHA, ELIQUIS, Ozempic, PREVNAR 20, Wegovy, FREESTYLE LIBRE 3, Cologuard Collection Kit, VRAYLAR.
Industry payments across TN — which companies pay providers there.
